Gregg Williams, a director and 10% shareholder of Vivani Medical, Inc. (NASDAQ: VANI), has completed a significant acquisition of the company's common stock. On June 15, 2026, Williams purchased 1,587,301 shares at a price of $1.26 per share, totaling $1,999,999. This transaction was facilitated through a private sale, as outlined in a Share Purchase Agreement dated August 11, 2025. The purchase price of $1.26 per share aligned with the last reported sale price of Vivani Medical's common stock on the Nasdaq on August 10, 2025, the day prior to the agreement's date. The stock is currently trading at $1.13, which is below Williams' acquisition price, reflecting the company's volatile nature with a beta of 3.29.
Following this transaction, Mr. Williams' total beneficial ownership in Vivani Medical stands at 40,918,286 shares. This includes 4,799,200 shares owned directly by Mr. Williams. The remaining shares are held indirectly through various entities: 33,993,334 shares by the Gregg G. Williams 2006 Trust, 1,212,856 shares by Williams International Co. LLC, 181,587 shares by Sam Williams Family Investments LLC, and 731,309 shares by the Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams retains voting and dispositive power over all these shares.
While Vivani Medical has a "WEAK" financial health score on InvestingPro, analysts see significant upside potential with price targets ranging from $3.50 to $7.00. This insider buying activity may signal confidence in the company's future prospects, despite the current market conditions and the company's financial health score.